Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Carillon Eagle Small Cap Growth Fund's investment thesis on Cellebrite ($CLBT) — Q2 2025 | Buyside Digest

All Pitches

View Letter Analysis

$CLBTNASDAQCellebrite

BULL

Carillon Eagle Small Cap Growth Fund—CLBT

Fund Letter

Q2 2025

Published June 30, 2025

View Fund Profile

$15.44USD

+34.8% vs last month

$15.45Pitched

-0.1% since pitch

Market Cap$3.9B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

The Carillon Eagle Small Cap Growth Fund's second quarter 2025 commentary discusses a highly turbulent period for small-cap equities, followed by a strong recovery. Driven by historically...

— Eric Mintz, Christopher Sassouni, David Cavanaugh

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $CLBT, and what else Carillon Eagle Small Cap Growth Fund is buying.

Other pitches on $CLBT

Other investors who've written on Cellebrite

No other institutional pitches found for this ticker yet.

View all $CLBT pitches →